IPP Bureau
Sputnik V launch to lift near-term outlook for Dr. Reddy's Labs: HDFC Securities
By IPP Bureau - May 18, 2021
Dr. Reddy's has the rights to distribute 250mn doses in India
Outlook intact for Dr. Reddy's Laboratories : ICICI Securities
By IPP Bureau - May 18, 2021
India sales grew 23.5% YoY with consolidation of Wockhardt products
Govt. to supply 1.92 crore COVID vaccines during May 16-31
By IPP Bureau - May 16, 2021
A total quantum of more than 4.39 crore doses was also available for direct procurement by the states as well as private hospitals in the month of May 2021
Aarti Drugs Q4FY21 consolidated net profit drops to Rs. 51.65 Cr
By IPP Bureau - May 16, 2021
Aarti Drugs has reported total income of Rs.2159.30 crores during the 12 months period ended March 31, 2021
Cadila Healthcare divests animal health business: ICICI Securities
By IPP Bureau - May 16, 2021
The company plans to aggressively invest in longer gestation period projects like innovation, biosimilars, vaccines, etc.
Govt. to augment Covaxin production by 10 crore doses
By IPP Bureau - May 16, 2021
Financial support is being provided as a grant from the Government of India
SPARC announces positive results from Phase 3 trial of PDP-716
By IPP Bureau - May 15, 2021
The trial met its pre-specified primary endpoint, demonstrating that PDP-716 dosed once daily is equivalent to Alphagan P 0.1% dosed 3 times a day
Alembic gets USFDA approval for Lurasidone Hydrochloride tablets
By IPP Bureau - May 15, 2021
Lurasidone Hydrochloride tablets are also indicated for adjunctive treatment with lithium or valproate in adult patients with major depressive episode associated with bipolar I disorder
Dr. Reddy's Sputnik V India price is Rs. 995.40
By IPP Bureau - May 15, 2021
The company is working closely with its six manufacturing partners in India
Dr. Reddy's Laboratories see marginal dip in FY 2021 PAT
By IPP Bureau - May 15, 2021
Dr. Reddy's Laboratories has reported total income of Rs.19338.9 crores during FY ended March 31, 2021
Cipla reports Q4FY21 consolidated net profit of Rs. 413.38 Cr
By IPP Bureau - May 15, 2021
The company has reported total income of Rs.19425.58 crores during FY ended March 31, 2021
Granules to donate 16 crores Paracetamol tablets to Telangana
By IPP Bureau - May 15, 2021
The company will provide one crore tablets every week, starting from 12th May 2021, aggregating to 16 crore tablets worth Rs. 8 crores over the next 4 months
Gap between two doses of Covishield extended; No extension for Covaxin
By IPP Bureau - May 14, 2021
The COVID Working Group has recommended extension of the gap between the first and second doses of Covishield
Govt. to allow 100% doses of imported and ready to use foreign vaccine
By IPP Bureau - May 14, 2021
Proactively engaging with foreign vaccine manufacturers like Moderna, Pfizer etc., to apply for Emergency Use Authorization in India so that these vaccines can be easily imported and made available in India
Zydus Cadila entity to sell its India focused animal health business to a consortium
By IPP Bureau - May 13, 2021
The deal is to sell one of the two business undertakings of ZAHL for a lump sum consideration of Rs. 2921 crores on a cash free and debt free basis,
